Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6

14Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Context: Inflammatory, endothelial and neurohormonal biomarkers are involved in heart failure (HF) and pulmonary hypertension (PH) pathogenesis. Objective: To study these biomarkers in PH due to advanced HF. Materials and methods: Thirty adults with HF were included. Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hsCRP), endothelin-1 and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) were measured in peripheral vein and pulmonary artery during right heart catheterisation. Results: IL-6, TNF-α, hsCRP and NT-proBNP correlated with pulmonary pressures independent of ventricular function, HF etiology and vascular bed. IL-6 was independent predictor of systolic pulmonary artery pressure (sPAP). Discussion and conclusion: Inflammatory biomarkers correlate to PH severity. IL-6 predicts sPAP in advanced HF. © 2014 Informa UK Ltd.

Cite

CITATION STYLE

APA

Dolenc, J., Šebeštjen, M., Vrtovec, B., Koželj, M., & Haddad, F. (2014). Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6. Biomarkers, 19(5), 385–390. https://doi.org/10.3109/1354750X.2014.918654

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free